Trial · NCT04052425
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Anal fistula | Gastrointestinal disorders | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Anal fistula | Gastrointestinal disorders | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Appendicitis | Infections and infestations | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Appendicitis | Infections and infestations | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Concussion | Injury, poisoning and procedural complications | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Concussion | Injury, poisoning and procedural complications | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Hepatitis infectious mononucleosis | Infections and infestations | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Hepatitis infectious mononucleosis | Infections and infestations | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Hypersensitivity | Immune system disorders | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Hypersensitivity | Immune system disorders | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Kidney contusion | Injury, poisoning and procedural complications | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Kidney contusion | Injury, poisoning and procedural complications | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Myocarditis | Cardiac disorders | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Myocarditis | Cardiac disorders | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Subacute combined cord degeneration | Nervous system disorders | Vehicle Cream BID | 0 | 109 | 0 |
| serious | Subacute combined cord degeneration | Nervous system disorders | Ruxolitinib Cream 1.5% BID | 1 | 311 | 1 |
| serious | Tibia fracture | Injury, poisoning and procedural complications | Vehicle Cream BID | 1 | 109 | 1 |
| serious | Tibia fracture | Injury, poisoning and procedural complications | Ruxolitinib Cream 1.5% BID | 0 | 311 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04052425/events